{"prompt": "['Abbreviated Title: Ph II SGI110 in Peds & Adults', '11', 'Version Date: 07/22/2019', '16.3.5 Adult Patient PROMIS Instruments Spanish (6)', 'PROMIS Item Bank V. 1.2 - Physical Function - Short Form 10a', 'Capacidad de funcionamiento f\u00edsico - Cuestionario abreviado 10a', 'Responda a cada pregunta marcando una casilla por l\u00ednea.', 'No puedo', 'Nada', 'Poco', 'Algo', 'Mucho', 'hacerlo', '\u00bfLimita su salud en este momento su capacidad', 'PFA1', 'para realizar actividades vigorosas, como correr,', '5', '4', '3', '2', '1', 'levantar objetos pesados o participar en deportes', 'en\u00e9rgicos?', 'Limita su salud en este momento su capacidad', 'PFC36r1', 'para caminar m\u00e1s de una milla (1.6 km)?', '5', '4', '3', '2', '1', 'PFC37', '\u00bfLimita su salud en este momento su capacidad', 'para subir un piso de escaleras?', '5', '4', '3', '2', '1', '\u00a1Limita su salud en este momento su capacidad', 'PFAS', 'para levantar o llevar las bolsas del', '5', '4', '3', '2', '1', 'supermercado?', '\u00bfLimita su salud en este momento su capacidad', 'PFA3', 'para inclinarse, arrodillarse o agacharse?', '5', '4', '3', '2', '1', 'Con', 'Con', 'Sin', 'Con poca', 'alguna', 'mucha', 'No puedo', 'dificultad', 'dificultad', 'dificultad', 'dificultad', 'hacerlo', 'PFA11', '\u00bfPuede realizar tareas, como pasar la aspiradora', '5', '4', '3', '2', '1', 'o trabajar en el jardin?', 'PFA16r1', '\u00bfPuede vestirse sin ayuda, incluso amarrarse los', '5', '4', '3', '2', '1', 'zapatos y abotonarse la ropa?', 'PFB26', '\u00bfPuede lavarse el cabello con champ\u00fa?', '5', '3', '2', '1', 'PFA55', '\u00bfPuede lavarse y secarse el cuerpo?', '5', '4', '3', '2', '1', 'PFC45r1', '\u00bfPuede sentarse y levantarse del inodoro', '(excusado)?', '5', '4', '3', '2', '1', 'Spanish (Universal)', '21 January 2014', '\u00a9 2008-2013 PROMIS Health Organization and PROMIS Cooperative Group', 'Page of 1', '84', '16.4', 'Appendix IV: The Distress and Symptom Checklist: The Distress Thermometer 90', '17 REFERENCES', '92']['Abbreviated Title: Ph II SGI110 in Peds & Adults', '12', 'Version Date: 07/22/2019', '1', 'INTRODUCTION', '1.1', 'STUDY OBJECTIVES', '1.1.1 Primary Objective', 'To assess the clinical activity (CR or PR) of SGI-110 in patients with wt-GIST, SDH-', 'deficient PHEO/PGL, and HLRCC-associated renal cell carcinoma using RECIST (v1.1).', '1.1.2 Secondary', '1.1.2.1 Evaluate the toxicity, progression-free (PFS) and overall survival (OS), and pain and', 'quality of life (QOL) of patients on treatment with SGI-110.', '1.1.2.2', 'Better define the pharmacokinetics (PK) of SGI-110 in all patients.', '1.1.3', 'Exploratory', '1.1.3.1', 'Determine the serum and urine concentration of succinate, fumarate and 2-', 'hydroxyglutarate in patients with wild-type GIST, pheochromocytoma and', 'paraganglioma associated with SDH deficiency and HLRCC-associated kidney', 'cancer prior to and on therapy with SGI-110.', '1.1.3.2', 'Explore changes in DNA methylation and gene expression including SDH, FH, and', 'tumor testis antigens in response to treatment with SGI-110.', '1.1.3.3 Assess the global DNA methylation status in tumors by determining LINE-1', 'methylation in archival pre-treatment tumor samples and in on-treatment tumor', 'samples when available.', '2', 'BACKGROUND AND RATIONALE', '2.1.1 Background', 'Loss of activity of the Krebs cycle components succinate dehydrogenase (SDH) complex or', 'fumarate hydratase (FH), has been identified as a mechanism of tumorigenesis in subsets of', 'gastrointestinal stromal tumor (GIST), pheochromocytoma and paraganglioma (PHEO/PGL),', 'and renal cell carcinoma.', 'DNA hyper-methylation has been demonstrated in these cancers 2,6,7 Loss of activity of SDH', 'or FH leads to accumulation of the metabolites succinate and fumarate, respectively.', 'Succinate and fumarate act as inhibitors of a broad array of a-ketoglutarate-dependent', 'dioxygenases. The Ten-eleven Translocation (TET) family of dioxengenase', 'enzymes convert 5-methylcytosine to 5-hydroxymethycytosine leading to DNA', 'demethylation. Inhibition of these enzymes due to SDH and FH deficiency causes DNA', 'hypermethylation8. It is hypothesized that a methylation inhibitor would impact tumor growth', 'by reversing the DNA hypermethylation that is seen in this group of tumors with Krebs cycle', 'abnormalities.', '2.1.2 Gastrointestinal stromal tumors', 'Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumor of the', 'gastrointestinal tract, resistant to cytotoxic chemotherapy and radiation therapy. KIT and', 'PDGFRA mutations have been identified as tumor initiating events in 85% of adult patients', 'with GIST and these tumors are responsive to the tyrosine kinase inhibitor, Imatinib9. In', 'pediatric patients, however, 85% of GISTs lack KIT and PDGFRA mutations (wild-type']\n\n###\n\n", "completion": "END"}